These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 26306713)

  • 1. Proficiency testing in immunohistochemistry--experiences from Nordic Immunohistochemical Quality Control (NordiQC).
    Vyberg M; Nielsen S
    Virchows Arch; 2016 Jan; 468(1):19-29. PubMed ID: 26306713
    [TBL] [Abstract][Full Text] [Related]  

  • 2. External quality assessment for immunohistochemistry: experiences from NordiQC.
    Nielsen S
    Biotech Histochem; 2015 Jul; 90(5):331-40. PubMed ID: 25901597
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lessons Learned, Challenges Taken, and Actions Made for "Precision" Immunohistochemistry. Analysis and Perspectives From the NordiQC Proficiency Testing Program.
    Nielsen S; Bzorek M; Vyberg M; Røge R
    Appl Immunohistochem Mol Morphol; 2023 Aug; 31(7):452-458. PubMed ID: 36194495
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A National Quality Assurance program for breast immunohistochemistry: an Italian perspective.
    Guadagno E; De Rosa G; Nappi O
    Pathologica; 2018 Sep; 110(2):83-91. PubMed ID: 30546143
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NordiQC Assessments of Keratin 5 Immunoassays.
    Thomsen C; Nielsen O; Nielsen S; Røge R; Vyberg M
    Appl Immunohistochem Mol Morphol; 2020 Aug; 28(7):566-570. PubMed ID: 32243261
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunohistochemistry practices of cytopathology laboratories: a survey of participants in the College of American Pathologists Nongynecologic Cytopathology Education Program.
    Fischer AH; Schwartz MR; Moriarty AT; Wilbur DC; Souers R; Fatheree L; Booth CN; Clayton AC; Kurtyz DF; Padmanabhan V; Crothers BA
    Arch Pathol Lab Med; 2014 Sep; 138(9):1167-72. PubMed ID: 24840035
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analytic Validation of Immunohistochemistry Assays: New Benchmark Data From a Survey of 1085 Laboratories.
    Stuart LN; Volmar KE; Nowak JA; Fatheree LA; Souers RJ; Fitzgibbons PL; Goldsmith JD; Astles JR; Nakhleh RE
    Arch Pathol Lab Med; 2017 Sep; 141(9):1255-1261. PubMed ID: 28557616
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An Audit of Failed Immunohistochemical Slides in a Clinical Laboratory: The Role of On-Slide Controls.
    Cheung CC; Taylor CR; Torlakovic EE
    Appl Immunohistochem Mol Morphol; 2017; 25(5):308-312. PubMed ID: 26657875
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of Primary Antibody Clone, Format, and Stainer Platform on Ki67 Proliferation Indices in Breast Carcinomas.
    Røge R; Nielsen S; Riber-Hansen R; Vyberg M
    Appl Immunohistochem Mol Morphol; 2019; 27(10):732-739. PubMed ID: 31460869
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NordiQC Assessments of Chromogranin A Immunoassays.
    Røge R; Kristoffersen HL; Bzorek M; Nielsen O; Vyberg M
    Appl Immunohistochem Mol Morphol; 2019 Apr; 27(4):258-262. PubMed ID: 30653032
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Academic and nonacademic laboratories perform equally on CIQC immunohistochemistry proficiency testing.
    Chen ZW; Neufeld H; Copete MA; Garratt J; Gilks CB; Torlakovic EE
    Am J Clin Pathol; 2013 Jul; 140(1):55-60. PubMed ID: 23765534
    [TBL] [Abstract][Full Text] [Related]  

  • 12. External quality assessment: best practice.
    James D; Ames D; Lopez B; Still R; Simpson W; Twomey P
    J Clin Pathol; 2014 Aug; 67(8):651-5. PubMed ID: 24621574
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NordiQC Assessments of CD117 Immunoassays.
    Røge R; Bzorek M; Nielsen O; Vyberg M
    Appl Immunohistochem Mol Morphol; 2019 Feb; 27(2):87-91. PubMed ID: 30499819
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunohistochemical expression of HER2 in breast cancer: socioeconomic impact of inaccurate tests.
    Vyberg M; Nielsen S; Røge R; Sheppard B; Ranger-Moore J; Walk E; Gartemann J; Rohr UP; Teichgräber V
    BMC Health Serv Res; 2015 Aug; 15():352. PubMed ID: 26318869
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Developing ALK Immunohistochemistry and In Situ Hybridization Proficiency Testing for Non-Small Cell Lung Cancer in Canada: Canadian Immunohistochemistry Quality Control Challenges and Successes.
    Cheung CC; Garratt J; Won J; Cutz JC; Gilks BC; Tsao M; Torlakovic EE
    Appl Immunohistochem Mol Morphol; 2015; 23(10):677-81. PubMed ID: 26551338
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Laboratory compliance with the American Society of Clinical Oncology/College of American Pathologists human epidermal growth factor receptor 2 testing guidelines: a 3-year comparison of validation procedures.
    Dyhdalo KS; Fitzgibbons PL; Goldsmith JD; Souers RJ; Nakhleh RE
    Arch Pathol Lab Med; 2014 Jul; 138(7):876-84. PubMed ID: 24978913
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nordic immunohistochemical quality control.
    Vyberg M; Torlakovic E; Seidal T; Risberg B; Helin H; Nielsen S
    Croat Med J; 2005 Jun; 46(3):368-71. PubMed ID: 15861513
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Implementing a regional integrated laboratory proficiency testing scheme for peripheral health facilities in East Africa.
    Munene S; Songok J; Munene D; Carter J
    Biochem Med (Zagreb); 2017 Feb; 27(1):110-103. PubMed ID: 28392733
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analytical performances of food microbiology laboratories - critical analysis of 7 years of proficiency testing results.
    Abdel Massih M; Planchon V; Polet M; Dierick K; Mahillon J
    J Appl Microbiol; 2016 Feb; 120(2):346-54. PubMed ID: 26599261
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.